Back to top
more

Universal Health Services, Inc. (UHS)

(Delayed Data from NYSE)

$106.43 USD

106.43
803,571

-1.41 (-1.31%)

Updated Sep 22, 2020 04:00 PM ET

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.33%
2Buy17.77%
3Hold9.37%
4Sell4.88%
5Strong Sell1.79%
S&P50010.56%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 49% (129 out of 251)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Zacks News

Zacks Equity Research

Why Should You Retain MEDNAX (MD) in Your Portfolio Now?

Riding on restructuring as well as cost-cutting initiatives, MEDNAX (MD) holds potential to reap benefits for investors.

Zacks Equity Research

Why Should You Add Universal Health (UHS) to Your Portfolio?

Riding high on segmental contributions and a solid balance sheet, Universal Health (UHS) has potential to reap benefits for investors.

Zacks Equity Research

MEDNAX Divests Radiology Business to Focus on Core Operations

MEDNAX (MD) reaches an agreement with Radiology Partners to sell its MEDNAX Radiology Solutions, which will lower its debt load and restructure its business.

Zacks Equity Research

MEDNAX (MD) Catches Eye: Stock Jumps 5.4%

MEDNAX (MD) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Zacks Equity Research

The Zacks Analyst Blog Highlights: HUM, SEM, UHS and FSNUY

The Zacks Analyst Blog Highlights: HUM, SEM, UHS and FSNUY

Zacks Equity Research

Why Should You Hold on to Tenet Healthcare (THC) Stock?

Riding high on divestitures and cost-reduction, Tenet Healthcare (THC) holds enough potential to reap benefits for yield-seeking investors.

Sejuti Banerjea

How to Invest After the Market Selloff

Tried and tested methods always work best when you're faced with increased uncertainty and volatility.

Swayta Shah

Impressive Sales Growth Makes These 5 Stocks Worth Buying

Sales growth is an important indicator of a company's health and ability to sustain the business.

Zacks Equity Research

Why Is Universal Health Services (UHS) Up 0.6% Since Last Earnings Report?

Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Ensign Group (ENSG) Continues to Gain From Buyout Binge

Ensign Group's (ENSG) series of buyouts poise it well for growth by enhancing its capabilities, both financially and clinically.

Zacks Equity Research

Ensign Group's (ENSG) Q2 Earnings Beat Estimates, Rise Y/Y

Ensign Group's (ENSG) Q2 earnings results reflect better revenues from its Transitional and Skilled Services segment.

Zacks Equity Research

Humana's (HUM) Q2 Earnings Surpass Estimates, Improve Y/Y

Humana's (HUM) Q2 earnings reflect better revenues and solid contributions from its Retail and Healthcare Services segments.

Zacks Equity Research

Tenet Healthcare (THC) Q2 Earnings Beat Estimates, Rise Y/Y

Tenet Healthcare's (THC) Q2 earnings gain from operational performance, partly offset by lower revenues.

Zacks Equity Research

Select Medical's (SEM) Q2 Earnings Beat Estimates, Rise Y/Y

Select Medical's (SEM) second-quarter earnings performance benefits from lower expenses.

Zacks Equity Research

MEDNAX's (MD) Q2 Earnings Surpass Estimates, Decline Y/Y

MEDNAX's (MD) Q2 results reflect lower expenses, offset by soft revenues.

Zacks Equity Research

Molina Healthcare (MOH) Q2 Earnings Beat Estimates, Rise Y/Y

Molina Healthcare's (MOH) Q2 results reflect higher revenues and membership growth.

Zacks Equity Research

Teladoc (TDOC) Q2 Earnings Lag Estimates, Revenues Up Y/Y

Teladoc's (TDOC) second-quarter results reflect higher revenues and solid rise in patient visits, partially offset by increased expenses.

Zacks Equity Research

Anthem (ANTM) Q2 Earnings Surpass Estimates, Improve Y/Y

Anthem's (ANTM) Q2 results reflect higher premium revenues and a solid contribution from Government business.

Zacks Equity Research

Community Health (CYH) Q2 Earnings Beat, Revenues Down Y/Y

Community Health's (CYH) second-quarter results reflect lower costs, partially offset by softer revenues owing to decline in admissions.

Zacks Equity Research

Universal Health (UHS) Q2 Earnings Beat, Revenues Down Y/Y

Universal Health's (UHS) second-quarter earnings reflect lower expenses, partially offset by reduced patient volumes.

Zacks Equity Research

Universal Health Services (UHS) Q2 Earnings and Revenues Beat Estimates

Universal Health Services (UHS) delivered earnings and revenue surprises of 463.46% and 12.41%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Universal Health (UHS) to Report Q2 Earnings: What to Expect

Universal Health's (UHS) second-quarter results are likely to reflect muted revenues.

Zacks Equity Research

Is a Surprise Coming for Universal Health Services (UHS) This Earnings Season?

Universal Health Services (UHS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Equity Research

What's in Store for HCA Healthcare's (HCA) Q2 Earnings?

HCA Healthcare's (HCA) second-quarter results are likely to reflect dented revenues due to the pandemic woes.

Zacks Equity Research

Universal Health Services (UHS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Universal Health Services (UHS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.